Rare Renal Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
  • Rare Renal Disorders Home
    • Product
      PH1 Product Information Product Resources Library
  • Contact Your Representative
    • Disease Education
      What Is PH1? Identifying & Diagnosing
    • Product Education
      Patient Education Materials
    • Additional Resources
      Professional & Patient Organizations
  • Sign In
    Create Account
    • Account Settings
    • Sign Out
    Other Therapy Areas
    Medical Information
    Non-US Health Care Professionals
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg logo
Important Safety Information | Patient Site
Prescribing Information
  • Understanding PH1
  • About Rivfloza®
  • Efficacy and Safety
  • Dosing and Administration
  • Start Your Patients
  • Resources
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg logo

For adults and children aged 2 years and older with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Prescribing Information
Important Safety Information | Patient Site

Rivfloza® (nedosiran) injection offers your patients self-administered, once-monthly dosing1

Offer your patients at-home self-administration with once-monthly Rivfloza®.1

Rivfloza® (nedosiran) injection offers your patients self-administered, once-monthly dosing1

Offer your patients at-home self-administration with once-monthly Rivfloza®.1

House icon

At-home self-administration1

At-home self-administration1

After proper training:

  • Rivfloza® can be self- or caregiver-administered at home using a single-dose prefilled syringe or by vial.
  • For children aged 2 to less than 12 years, Rivfloza® may be administered by a caregiver under guidance and supervision of a health care professional.
Mother doing her daughter's hair Mother doing her daughter's hair
Calendar icon

Monthly dosing1

Monthly dosing1

  • Rivfloza® is administered once monthly via subcutaneous injection at the recommended weight- and age-based dose.
  • No loading dose or titration schedule is required.
  • If a patient misses a dose, advise to inject the dose as soon as possible. If a dose is missed by more than 7 days, inject the dose as soon as possible and resume monthly dosing from the most recently injected dose.
Rivfloza® cartons, vial, and prefilled syringe
Rivfloza® cartons, vial, and prefilled syringe

Dosing regimen for Rivfloza® is determined by age and body weight1

Rivfloza® dosing chart
Rivfloza® dosing chart
Download dosing guide

Learn more about administering Rivfloza®

Please see page 6 of the Prescribing Information for the Instructions for Use.

For patients using the prefilled syringe

Rivfloza® Administration Video - Pre-Filled Syringe (PFS) Injection
(06:38)

This is a demonstration of how to prepare and administer Rivfloza®. Read the Instructions for Use provided with the medication before using Rivfloza® and each time you refill. There may be new information. Please see the accompanying Prescribing Information (PI), including Instructions for Use, located in each carton of Rivfloza®. Ask your or your child’s healthcare provider if you have any questions. To learn more about Rivfloza® and available support programs, visit Rivfloza.com.

What is Rivfloza®? Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function. It is not known if Rivfloza® is safe and effective in children younger than 2 years of age.

Important Safety Information. What are the possible side effects of Rivfloza®? The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Important information you need to know before injecting Rivfloza®. Your or your child’s healthcare provider will show you how to prepare and inject Rivfloza® before you use the Pre-filled Syringe for the first time. Use the Rivfloza® Pre-filled Syringe exactly as your or your child’s healthcare provider tells you to. In children 2 to less than 12 years of age weighing 86 pounds (39 kilograms) or more, it is recommended that the Rivfloza® Pre-filled Syringe be given by a healthcare provider or caregiver. Your or your child’s healthcare provider will tell you when and how to inject Rivfloza®.

Rivfloza® Pre-filled Syringe is a single-dose Pre-filled Syringe for one-time (single) use only. Do not reuse your Pre-filled Syringe. Rivfloza® Pre-filled Syringe is for injection under the skin (subcutaneous injection) only. Do not inject Rivfloza® into a vein.

Preparing Your Injection. Gather supplies and place them on a clean, flat surface in a well-lit area. The Rivfloza® Injection Mat works well to help you gather supplies. Remove the Rivfloza® Pre-filled Syringe carton from the refrigerator. Make sure the carton contains the correct dose. Check the expiration date. Wait 30 minutes to allow the medicine to reach room temperature. Do not warm the Pre-filled Syringe, using any heat source, such as hot water or a microwave. Wash your hands with soap and water. Open the carton and remove the Pre-filled Syringe. Grip the barrel of the Pre-filled Syringe and remove it from the carton. Inspect the Pre-filled Syringe. Look at the medicine inside. It should appear colorless to yellow and free of particles.

Choose the injection site. The medicine may be injected into the skin of the stomach area at least 2 inches from the belly button, or the upper thigh. Caution: Do not inject into scarred or bruised skin. Clean injection site. Clean the injection site with an alcohol wipe and let it air dry.

Giving Your Injection. Remove the needle cap and throw it away in a sharps disposal container. Hold the Pre-filled Syringe with 1 hand with the needle pointed away from you. Pull the needle cap straight off with the other hand. Caution: If the needle appears to be bent or damaged, do not use the Pre-filled Syringe. Caution: Do not touch or recap the needle. Caution: Do not touch the plunger until you are ready to inject. Pinch the skin and fully insert the needle. Pinch the skin around injection site with 1 hand. Grasp the finger grip portion of the Pre-filled Syringe with the other hand and fully insert needle into injection site at a 45-degree angle. Slowly inject all the medicine. Gently push the plunger rod all the way down until the Pre-filled Syringe is empty. The rubber stopper inside the Pre-filled Syringe moves to the bottom of the barrel as the medicine is injected. Remove the Pre-filled Syringe from the injection site. Do not recap the needle. If there is bleeding, lightly press a cotton ball or gauze over the injection site.

After Your Injection. Throw away (dispose of) the used Pre-filled Syringe. Put the used Pre-filled Syringe in a FDA-cleared sharps disposal container right away after use. If a FDA-cleared sharps disposal container is not available, you may use a household container that is: made of heavy-duty plastic, can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out, upright and stable during use, leak-resistant, and properly labeled to warn of the hazardous waste inside the container. You should throw away unused portion of the medicine. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at www.fda.gov/safesharpsdisposal.

Please see the Prescribing Information (PI), including the Instructions for Use, located in each carton of Rivfloza®. Questions? NovoCare® is here to assist you if you have any questions Monday-Friday 8 am – 8 pm EST, at 1-844-906-5099.
US25RVZA00015

For patients using the single-dose vial

Rivfloza® Administration Video - Vial
(08:47)

This is a demonstration of how to prepare and administer Rivfloza®. Read the Instructions for Use provided with the medication before using Rivfloza® and each time you refill. There may be new information. Please see the accompanying Prescribing Information (PI), including the Instructions for Use located in each carton of Rivfloza®. Ask your or your child’s healthcare provider if you have any questions. To learn more about Rivfloza® and available support programs, visit Rivfloza.com.

What is Rivfloza®? Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function. It is not known if Rivfloza® is safe and effective in children younger than 2 years of age.

Important Safety Information. What are the possible side effects of Rivfloza®? The most common side effects of Rivfloza® include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Important information you need to know before injecting Rivfloza®. Your or your child’s healthcare provider will show you how to prepare and inject Rivfloza®. Do not try to inject Rivfloza® until you have been shown the right way by your or your child’s healthcare provider. Use the Rivfloza® vials exactly as your or your child’s healthcare provider tells you to. Your or your child’s healthcare provider will tell you how much Rivfloza® to inject and when to inject it. Rivfloza® vials are for one-time use (single-dose) only. Do not reuse the Rivfloza® vial. Throw away (or discard of) any unused Rivfloza®. Rivfloza® is for injection under the skin (subcutaneous injection) only. Do not inject Rivfloza® into a vein. Your Rivfloza® Injection Mat is available in the Rivfloza® Starter Kit or by calling NovoCare® at 1-844-906-5099.

Preparing Your Injection. Gather your supplies and place them on a clean, flat surface in a well-lit area. The Rivfloza® Injection Mat works well to help you gather supplies. Remove the Rivfloza® vial carton(s) from the refrigerator. Check the expiration date on the carton or cartons. Wait 30 minutes to allow the medication to reach room temperature. Do not warm the vial, using any heat source, such as hot water or a microwave. Your medication may have 1 or 2 vials of Rivfloza® and 1 or 2 syringes depending on the prescribed dose. Wash your hands with soap and water. Open the carton(s) and remove the vial(s). Check the vial label to make sure it’s the correct medicine for your or your child’s prescription. Inspect vial(s). Look at the medicine in the vial. It should appear colorless to yellow and free of particles.

Choose the injection site. The medicine may be injected into the skin of the stomach area at least 2 inches from the belly button, or into the upper thigh. Caution: Do not inject into scarred or bruised skin. Do not inject the contents of 2 syringes into the same location. Clean the injection site(s). Clean the injection site(s) with an alcohol wipe and let it air dry.

Prepare the vial(s). Remove the cap from the vial(s). Clean the top of the grey rubber stopper with a new alcohol wipe.

Giving Your Injection. Your syringe may look slightly different. Remove the syringe with the attached needle from the packaging and remove the needle cap. Throw the needle cap away in a sharps disposal container. Caution: Take care when handling the uncapped needle. Do not touch the uncapped needle. Withdraw Rivfloza® into the syringe. If the dose amount is 0.5 mL or less: insert the needle into the grey rubber stopper on top of the vial. Turn the vial and syringe upside down. Keep the tip of the needle in the medicine. Hold the syringe and vial in 1 hand. With your other hand, slowly pull back on the plunger rod to withdraw the prescribed dose into the syringe. If the dose amount is 0.6 mL or more: you will need to withdraw the dose of Rivfloza® from 2 vials using 2 separate syringes. Follow “If the dose is 0.5 mL or less” instructions to withdraw the amount of medicine needed from each vial.

Follow these steps for each syringe. Remove any large air bubbles from the syringe. If large air bubbles appear in the syringe, tap the side of the syringe to move the air bubbles to the top of the syringe. Push the plunger rod up to push the air bubbles back into the vial. If the syringe doesn’t contain the correct dose after air bubbles are removed, pull back on the plunger rod again to the prescribed dose. Look at the syringe to make sure you have the correct amount for your or your child’s dose and is free of large air bubbles. Turn the vial and syringe back upright and remove the needle from the vial. Pinch the skin and fully insert the needle. Pinch the skin around the injection site with 1 hand. With the other hand, fully insert the needle into the skin at a 45-degree angle. Slowly inject all the medicine. Gently push the plunger rod all the way down until the syringe is empty. The rubber stopper inside the syringe moves to the bottom of the barrel as the medicine is injected. Remove the needle from the injection site. Throw away (dispose of) the used vial(s) in the household trash.

If there is bleeding, lightly press a cotton ball or gauze over the injection site. If the dose requires 2 vials, follow these steps to inject the second syringe into another area. Remember to inject at least 2 inches away from the belly button and to avoid scarred or bruised skin. Caution: Do not recap the needle. Do not save or keep used syringes.

After Your Injection. Throw away the used syringe(s). Put the used syringe(s) with the needle still attached in a FDA-cleared sharps disposal container right away after use. If a FDA-cleared sharps disposal container is not available, you may use a household container that is: made of heavy duty plastic, can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out, upright and stable during use, leak-resistant, and properly labeled to warn of the hazardous waste inside the container.

For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at www.fda.gov/safesharpsdisposal.

Please see the Prescribing Information (PI), including the Instructions for Use, located in each carton of Rivfloza®. Questions? NovoCare® is here to assist you if you have any questions, Monday-Friday 8 am – 8 pm EST, at 1-844-906-5099.
US25RVZA00014

Gene icon

Get your patients started on this RNAi therapy

Start here

RNAi=ribonucleic acid interference.

Person with headset icon

Have questions about Rivfloza®? Reach out to our team of representatives

Connect with a representative

Show More Show Less

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Please click here for Rivfloza® Prescribing Information.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Please click here for Rivfloza® Prescribing Information.

Reference:

  1. Rivfloza® [package insert]. Plainsboro, NJ: Novo Nordisk Inc.
Rare Renal Disorders
Other Therapy Areas
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy
  • Rare Renal Disorders Home
  • Product Information
    Product
    • PH1 Product Information
      Product Resources Library
  • Contact Your Representative
  • Professional Education
    Disease Education
    • What Is PH1?
      Identifying & Diagnosing
  • Patient Support
    Product Education
    • Patient Education Materials
    Additional Resources
    • Professional & Patient Organizations

PHYOX™ is a trademark and Rivfloza® is a registered trademark of Novo Nordisk Health Care AG.
novoMEDLINK™ is a trademark and NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Terms of Use | Privacy Notice | Consumer Health Privacy Notice | Cookie Notice | Privacy Request | Contact Us |
novonordisk-us.com    
© 2025 Novo Nordisk All rights reserved. US25RVZA00017  May 2025

Quick links